4
Changes in Ownership
Atara Biotherapeutics, Inc. Filed Acc 0000905148-24-002305
EVP, Chief Sci. & Tech Officer sold 1,821 shares at an average $6.63 ($12,072)
From the SEC's structured data for this filing
Trades in this filing
Nguyen AnhCo · EVP, Chief Sci. & Tech Officer
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-08-16 | Sale : show line 1 in the form | −1,468 | $6.63 | $9,731 | 34,471 | D |
| 2024-08-16 | Sale : show line 2 in the form | −297 | $6.63 | $1,969 | 34,174 | D |
| 2024-08-16 | Sale : show line 3 in the form | −56 | $6.63 | $371 | 34,118 | D |
| Open-market sales · 1,821 sh · avg $6.63 · $12,072 | ||||||
Loading xslF345X05/form4.xml…